enFeLV-derived Env proteins inhibit enFeLV and FeLV-B infection in the laboratory
Journal of virology · 2024
In plain language
In laboratory experiments, proteins derived from enFeLV, a retrovirus integrated into the cat genome, inhibited infection by enFeLV and FeLV-B. This mechanism has not been established to protect living cats. The study also does not demonstrate removal or switching off of FeLV already integrated into DNA. The available portions of the article do not allow assessment of how large the inhibition effect was or how uncertain that result is.
Scientific detail
The study published in Journal of Virology in 2024 (doi: 10.1128/jvi.01771-23) describes an enFeLV-derived restriction mechanism acting at receptor-dependent viral entry. In the reported in vitro experiments, soluble truncated Env proteins derived from enFeLV inhibited enFeLV and FeLV-B infection, a finding classified as level B evidence. The available Methods specify an empty-vector negative control, but the supplied text omits the detailed inhibition Results, preventing assessment of effect sizes and their uncertainty.
The tested infectious enFeLV Env pseudotypes infected mouse-derived MDTF cells expressing feline Pit1 but did not infect MDTF cells expressing feline Pit2. This finding supports receptor-dependent entry in that engineered cell system. It is classified as level D evidence because the target cells were non-feline, despite expressing feline receptors. It does not establish receptor usage in every feline tissue or unrestricted replication of enFeLV.
The proviral analyses addressed the genomic origin and evolutionary history of the Env proteins. The integration-time analysis used a domestic cat noncoding-region divergence rate as a substitute for the unknown enFeLV LTR mutation rate; this statement is classified as level E evidence. The resulting dates are computational estimates dependent on that surrogate rate, not directly observed integration events or measurements of integration kinetics during contemporary FeLV infection. Genome searches analyzed only proviruses containing an env gene.
The supplied text does not report an overall animal sample size. The Methods describe one female SPF domestic cat for tissue sampling and a genomic library derived from a single cat designated ON-T; these are distinct sampling descriptions and do not establish a total cohort size. Figure 2 reports three independent experiments for infection titers. Parenthetical numbers following references to domestic cats and European wildcats in the Methods are literature citations, not sample sizes. The supplied source omits a substantial portion of the Results and Discussion and does not include the actual figures or supplementary tables. The authors explicitly state that the exact in vivo roles of these soluble proteins remain unresolved. The study does not establish physiological protection against FeLV-B in living cats or removal or silencing of already integrated FeLV proviruses.
What we know
Soluble truncated Env proteins derived from enFeLV inhibited enFeLV and FeLV-B infection in the reported in vitro experiments (level B), although the available text does not allow assessment of the effect's magnitude or uncertainty. The tested infectious enFeLV Env pseudotypes infected mouse-derived MDTF cells expressing feline Pit1 but not those expressing feline Pit2 (level D). The integration-time analysis used a surrogate evolutionary rate because the enFeLV LTR mutation rate is unknown (level E).
What we don't know
The exact roles of soluble enFeLV-derived Env proteins in living organisms remain unresolved. These results do not establish protection against FeLV-B in living cats, receptor usage in every feline tissue, or removal or silencing of already integrated FeLV proviruses. The supplied text does not allow determination of the overall animal sample size or assessment of inhibition effect sizes and their uncertainty.
Evidence
EvidenceLevel B — Direct experimental evidenceConfidence 98/100
Soluble truncated Env proteins derived from enFeLV inhibited enFeLV and FeLV-B infection in the reported laboratory experiments.
Excerpt verified in the source — verbatim, in the source's own language“When soluble truncated Env proteins from enFeLV were tested for their inhibitory effects against enFeLV and FeLV-B, they inhibited viral infection.”
This is a directly reported FeLV-specific in vitro finding; the available Methods specify an empty-vector negative control. The detailed inhibition Results are omitted, so effect sizes and their uncertainty cannot be assessed here. This does not establish protection in living cats or effects on existing proviral integrations.
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 99/100
The tested infectious enFeLV Env pseudotypes infected mouse-derived MDTF cells expressing feline Pit1 but did not infect MDTF cells expressing feline Pit2.
Excerpt verified in the source — verbatim, in the source's own language“The results showed that MDTF-fePit1 cells were permissive to enFeLV Env-pseudotyped virus infection of clone1 E345G, clone2, clone3, and AGTT, whereas MDTF-fePit2 cells were not infected with any of the enFeLV Env-pseudotyped viruses ( Fig. 2D ).”
This directly supports receptor-dependent entry in an engineered mouse-cell system. Level D reflects the non-feline target cells under the requested evidence cap, despite expression of feline receptors. It does not establish receptor usage in every feline tissue or unrestricted replication of endogenous proviruses.
EvidenceLevel E — Computational hypothesisConfidence 100/100
The integration-time analysis substituted a domestic cat noncoding-region divergence rate for an unknown enFeLV LTR mutation rate.
Excerpt verified in the source — verbatim, in the source's own language“The mean divergence rate of noncoding regions in the domestic cat genome (1.2 × 10 −8 substitutions/site/year) was used because the mutation rate of LTRs in enFeLVs is unknown ( 80 ).”
The proviral integration dates are computational estimates dependent on a surrogate evolutionary rate, not directly observed integration events. This analysis does not measure integration kinetics during contemporary FeLV infection.
Open questionConfidence 100/100
The exact in vivo roles of the soluble enFeLV-derived Env proteins remain unresolved.
The surviving concluding discussion passage explicitly identifies this as a study limitation. The in vitro restriction findings therefore do not establish physiological protection against FeLV-B in living cats.
Provenance
Source: FeLIX is a restriction factor for mammalian retrovirus infection.
AVA